A Phase 1/2 Study of the Angiogenesis Inhibitor Sorafenib in Cervical Cancer Patients Treated With Radiation Therapy

被引：0
|
作者：
Chaudary, N. [1 ]
Fyles, T. W. [2 ]
Townsley, C. [3 ]
Han, K. [2 ]
Hill, R. P. [4 ]
Kim, S. [2 ]
Levin, W. [5 ]
MacKay, H. [5 ]
Manchul, L. [5 ]
Yeung, I. [6 ]
Oza, A. [5 ]
Milosevic, M. [5 ]
机构：
[1] Princess Margaret Canc Ctr, Ontario Canc Inst, Toronto, ON, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[3] Womens Coll Hosp, Toronto, ON, Canada
[4] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada
[5] Princess Margaret Canc Ctr, Toronto, ON, Canada
[6] Southlake Reg Hlth Ctr, Toronto, ON, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.717
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1072
引用
收藏
页码：S187 / S188
页数：2
相关论文
共 50 条
  • [31] Randomized phase II study of immunomodulator Z-100 in patients with stage IIIB cervical cancer with radiation therapy
    Noda, Kiichiro
    Ohashi, Yasuo
    Okada, Hiroji
    Ogita, Sachio
    Ozaki, Masami
    Kikuchi, Yuzo
    Takegawa, Yoshihiro
    Niibe, Hideo
    Fujii, Shingo
    Horiuchi, Junichi
    Morita, Kozo
    Hashimoto, Shozo
    Fujiwara, Keiichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (09) : 570 - 577
  • [32] Weekly Image Guidance in Patients With Cervical Cancer Treated With Intensity-Modulated Radiation Therapy: Results of a Large Cohort Study
    Zeng, Zheng
    Wang, Weiping
    Yan, Junfang
    Liu, Dingchao
    Zhang, Fuquan
    Hu, Ke
    CANCER MEDICINE, 2024, 13 (18):
  • [33] A phase if study of preoperative capecitabine and radiation therapy in patients with rectal cancer
    Martin, M.
    Cerezo, L.
    Counago, F.
    Martin-Angulo, M.
    Lopez, M.
    Marin, A.
    Cruz, A.
    Rios, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S263 - S263
  • [34] A retrospective study of breast cancer patients treated with quadrantectomy without radiation therapy
    Shin E.
    Takatsuka Y.
    Okamura Y.
    Takeda M.
    Kobayashi T.
    Nishisho I.
    Kawahara K.
    Kurata A.
    Kikkawa N.
    Breast Cancer, 1999, 6 (2) : 109 - 116
  • [35] Sorafenib as a third line therapy in patients with epithelial ovarian cancer or primary peritoneal cancer: A phase II study
    Bodnar, Lubomir
    Gornas, Maria
    Szczylik, Cezary
    GYNECOLOGIC ONCOLOGY, 2011, 123 (01) : 33 - 36
  • [36] Assessment of Organ Motion in Postoperative Endometrial and Cervical Cancer Patients Treated with Intensity Modulated Radiation Therapy
    Rusthoven, C.
    Latifi, K.
    Javedan, K.
    Forster, K. M.
    Harris, E. E. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S362 - S362
  • [37] Outcomes For Cervical Cancer Patients Treated With Extended Field Intensity Modulated Radiation Therapy And Concurrent Cisplatin
    Jensen, L.
    Hasselle, M. D.
    Rose, B. S.
    Nath, S. K.
    Hasan, Y.
    Yashar, C. M.
    Mundt, A. J.
    Mell, L. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S452 - S453
  • [38] Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy
    Miller, TR
    Grigsby, PW
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (02): : 353 - 359
  • [39] Risk factors for fistula formation in patients with cervical cancer treated with radiation therapy include postradiation biopsy
    Feddock, J.
    DeSimone, C.
    Kudrimoti, M.
    Baldwin, L.
    Weiss, H.
    Randall, M.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S114 - S114
  • [40] Patient dose reduction in dynamic contrast enhanced CT scan: a longitudinal study for Sorafenib treated cervical cancer patients
    Kim, Mo
    Milosevic, Michael
    Haider, Masoom
    Jaffray, David
    Yeung, Ivan
    MEDICAL PHYSICS, 2019, 46 (11) : 5386 - 5386
12345